06.29.20

Novartis Withdraws Marketing Application of Dry Eye Drug Xiidra in Europe

Source: Eyewire News

04.06.20

EU Body Backs Compassionate Use of Gilead’s Remdesivir for COVID-19

Source: FirstWord

03.02.20

EMA Grants Two Product Designations to Janssen’s RPGR Gene Therapy for X-Linked Retinitis Pigmentosa

Source: Janssen

01.02.20

Aerie Pharmaceuticals Announces Acceptance for Review of the Roclanda Marketing Authorization Application in Europe

Source: Aerie Pharmaceuticals

12.16.19

Novartis Receives Positive CHMP Opinion for Beovu (Brolucizumab) for the Treatment of Wet AMD

Source: Novartis

09.20.19

Aerie Pharmaceuticals Receives Positive CHMP Opinion for Rhokiinsa in the European Union

Source: Aerie Pharmaceuticals

01.10.19

EMA Handed Down Fewer Positive Drug Opinions in 2018

Source: Medscape

View more stories